Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 29, 2021

SELL
$212.27 - $248.7 $232,011 - $271,829
-1,093 Closed
0 $0
Q2 2021

Jul 29, 2021

SELL
$233.58 - $259.14 $28,496 - $31,615
-122 Reduced 10.04%
1,093 $266,000
Q1 2021

Apr 28, 2021

SELL
$221.91 - $258.6 $51,039 - $59,478
-230 Reduced 15.92%
1,215 $302,000
Q3 2020

Oct 30, 2020

SELL
$234.65 - $260.95 $48,807 - $54,277
-208 Reduced 12.58%
1,445 $367,000
Q2 2020

Jul 31, 2020

SELL
$197.81 - $242.74 $4,945 - $6,068
-25 Reduced 1.49%
1,653 $390,000
Q1 2020

Apr 30, 2020

SELL
$182.24 - $241.7 $27,336 - $36,255
-150 Reduced 8.21%
1,678 $340,000
Q4 2019

Jan 31, 2020

SELL
$189.21 - $243.2 $1,324 - $1,702
-7 Reduced 0.38%
1,828 $441,000
Q3 2019

Nov 04, 2019

SELL
$174.11 - $208.62 $143,118 - $171,485
-822 Reduced 30.94%
1,835 $355,000
Q2 2019

Aug 08, 2019

BUY
$166.7 - $195.41 $8,001 - $9,379
48 Added 1.84%
2,657 $490,000
Q1 2019

Apr 30, 2019

SELL
$180.87 - $203.88 $323,938 - $365,149
-1,791 Reduced 40.7%
2,609 $496,000
Q4 2018

Feb 07, 2019

SELL
$178.4 - $208.25 $24,976 - $29,155
-140 Reduced 3.08%
4,400 $857,000
Q3 2018

Nov 06, 2018

SELL
$185.29 - $208.89 $87,086 - $98,178
-470 Reduced 9.38%
4,540 $941,000
Q1 2018

May 04, 2018

SELL
$169.43 - $198.0 $14,062 - $16,434
-83 Reduced 1.63%
5,010 $854,000
Q4 2017

Feb 02, 2018

BUY
$168.79 - $188.59 $309,392 - $345,685
1,833 Added 56.23%
5,093 $885,000
Q3 2017

Nov 07, 2017

BUY
$167.29 - $191.0 $545,365 - $622,660
3,260
3,260 $607,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Opus Capital Group, LLC Portfolio

Follow Opus Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opus Capital Group, LLC with notifications on news.